Notably, administration of tamoxifen at different doses did not change liver weight or body weight (Supplementary Fig. S8a) but reduced serum levels of ALT, AST, TC, and HDL-C (Supplementary Fig. S8b) and alleviated hepatic steatosis without difference (Supplementary Fig. S8c–e). This evidence concerns the gene GPT and Hepatic steatosis.